Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02235740
Title A Study Conducted in Subjects With Relapsed/Refractory Multiple Myeloma (MM); to Determine Dose of Afuresertib in Combination With Carfilzomib (Part 1) and to Investigate the Safety, Pharmacokinetic and Clinical Activity of the Combination Compared With Carfilzomib Alone (Part 2)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

multiple myeloma

Therapies

Carfilzomib

Afuresertib + Carfilzomib

Age Groups: adult
Covered Countries USA


No variant requirements are available.